Net-Pharma Hub

Net-Pharma Hub company information, Employees & Contact Information

Explore related pages

Related company profiles:

Net-Pharma es el primer Hub de empresas de referencia en Europa en servicios y tecnologías para el sector de las ciencias de la vida, compuesto por más de 30 empresas. Proporcionamos un ecosistema único que conecta a personas, empresas y organizaciones de la industria de la salud para generar crecimiento y networking, ofreciendo soluciones y servicios integrales y conocimiento experto, optimizando el tiempo y recursos de nuestros clientes y generando sinergias colaborativas que incrementan la cifra de negocio de nuestra comunidad de empresas. Promovemos a su vez el talento, la formación y la innovación. Buscamos fomentar el crecimiento del sector, desarrollando nuevos proyectos y soluciones que resuelvan las necesidades y retos de la industria, a través de: la búsqueda de sinergias para la prestación de soluciones integrales, el apoyo a iniciativas de vanguardia y la generación de capacidades y formaciones demandadas por la industria. Líneas de trabajo: • Soluciones Integrales 360 • Soporte a la Innovación • Formación Especializada

Company Details

Employees
24
Founded
-
Address
Carr. De Fuencarral, 22, Alcobendas, Madrid,madrid 28108,spain
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Madrid, Madrid
Looking for a particular Net-Pharma Hub employee's phone or email?

Net-Pharma Hub Questions

News

US net drug spending surged 11.4% last year, boosted by obesity and oncology meds: IQVIA - Fierce Pharma

US net drug spending surged 11.4% last year, boosted by obesity and oncology meds: IQVIA Fierce Pharma

Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds - Business Wire

Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds Business Wire

Net-Zero Pharma Supply Chain Market Size, Report by 2034 - Precedence Research

Net-Zero Pharma Supply Chain Market Size, Report by 2034 Precedence Research

Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement of Certain RSUs - GlobeNewswire

Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement of Certain RSUs GlobeNewswire

Kyowa, Amgen and Sanofi back push to change websites that miss the mark on women's health - Fierce Pharma

Kyowa, Amgen and Sanofi back push to change websites that miss the mark on women's health Fierce Pharma

Novartis says new drugs offset generic headwinds, including first for Entresto in US - FirstWord Pharma

Novartis says new drugs offset generic headwinds, including first for Entresto in US FirstWord Pharma

The Value of Pharmacy Benefit Managers - CVS Health

The Value of Pharmacy Benefit Managers CVS Health

Seven pharma CEOs announce new joint action to accelerate net zero healthcare - AstraZeneca

Seven pharma CEOs announce new joint action to accelerate net zero healthcare AstraZeneca

AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer - Fierce Pharma

AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer Fierce Pharma

Pharma’s path to Net Zero: Targeting Scope 3 emissions - Pharmaceutical Technology

Pharma’s path to Net Zero: Targeting Scope 3 emissions Pharmaceutical Technology

Harnessing Data to Improve Patient Access And Optimize Gross-to-Net - Fierce Pharma

Harnessing Data to Improve Patient Access And Optimize Gross-to-Net Fierce Pharma

With Taro's $419M deal, feds' price-fixing net snares another big settlement - Fierce Pharma

With Taro's $419M deal, feds' price-fixing net snares another big settlement Fierce Pharma

Argenx widens its Halozyme Therapeutics-partnered net with 4 new targets in $30M license expansion - Fierce Pharma

Argenx widens its Halozyme Therapeutics-partnered net with 4 new targets in $30M license expansion Fierce Pharma

Net prices for insulins keep dropping, but patients are paying more, Sanofi says - Fierce Pharma

Net prices for insulins keep dropping, but patients are paying more, Sanofi says Fierce Pharma

Sanofi's net prices keep slipping—despite list price hikes—thanks to billions in rebates - Fierce Pharma

Sanofi's net prices keep slipping—despite list price hikes—thanks to billions in rebates Fierce Pharma

The top 10 most profitable pharma companies in 2021 - Fierce Pharma

The top 10 most profitable pharma companies in 2021 Fierce Pharma

Catalyst holds firm on $300,000-plus net for Firdapse despite Bernie Sanders’ demands to justify the price - Fierce Pharma

Catalyst holds firm on $300,000-plus net for Firdapse despite Bernie Sanders’ demands to justify the price Fierce Pharma

Novartis CEO's 2023 pay rises 21% as Roche's helmsman nets $11M in his first year - Fierce Pharma

Novartis CEO's 2023 pay rises 21% as Roche's helmsman nets $11M in his first year Fierce Pharma

The top 20 drugs by worldwide sales in 2021 - Fierce Pharma

The top 20 drugs by worldwide sales in 2021 Fierce Pharma

DOJ issues subpoena to Celgene as feds cast a wider net in assistance-program probe - Fierce Pharma

DOJ issues subpoena to Celgene as feds cast a wider net in assistance-program probe Fierce Pharma

For sale: Amgen chops 60% off Repatha's $14,520 retail price - Fierce Pharma

For sale: Amgen chops 60% off Repatha's $14,520 retail price Fierce Pharma

Top 5 largest US pharma firms’ net earnings topped $81.9 billion last year: watchdog - The Hill

Top 5 largest US pharma firms’ net earnings topped $81.9 billion last year: watchdog The Hill

Will Amazon really get into drug sales? It's in talks with PBMs already, report says - Fierce Pharma

Will Amazon really get into drug sales? It's in talks with PBMs already, report says Fierce Pharma

UPDATED: During Moderna's 'transition year,' CEO Stéphane Bancel's total pay fell by about 12% - Fierce Pharma

UPDATED: During Moderna's 'transition year,' CEO Stéphane Bancel's total pay fell by about 12% Fierce Pharma

Accelerating the transition to net zero in life sciences - McKinsey & Company

Accelerating the transition to net zero in life sciences McKinsey & Company

Vivek Ramaswamy's Net Worth: How Harvard-Yale graduate became rich by selling 'sick' pharma companies - The Economic Times

Vivek Ramaswamy's Net Worth: How Harvard-Yale graduate became rich by selling 'sick' pharma companies The Economic Times

Amazon could partner with a PBM to blaze its trail into pharma: analysts - Fierce Pharma

Amazon could partner with a PBM to blaze its trail into pharma: analysts Fierce Pharma

Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds - Yahoo Finance

Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds Yahoo Finance

The World’s 50 Largest Pharmaceutical Companies - Visual Capitalist

The World’s 50 Largest Pharmaceutical Companies Visual Capitalist

Biotech and Pharma Aim for Net Zero, But Their Supply Chains Lag - Technology Networks

Biotech and Pharma Aim for Net Zero, But Their Supply Chains Lag Technology Networks

The CDMO Surge: Why Pharma Is Outsourcing More Than Ever - News-Medical

The CDMO Surge: Why Pharma Is Outsourcing More Than Ever News-Medical

US pharma giants combat emissions crisis with long-term net-zero pledges - S&P Global

US pharma giants combat emissions crisis with long-term net-zero pledges S&P Global

The top 10 most productive biopharma companies - Fierce Pharma

The top 10 most productive biopharma companies Fierce Pharma

Pfizer expects 8 blockbuster cancer drugs to come from each of 4 focus areas: exec - Fierce Pharma

Pfizer expects 8 blockbuster cancer drugs to come from each of 4 focus areas: exec Fierce Pharma

The top 20 highest-paid biopharma CEOs of 2018 - Fierce Pharma

The top 20 highest-paid biopharma CEOs of 2018 Fierce Pharma

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan - Yahoo Finance

Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan Yahoo Finance

Amgen cuts 500 U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital - Fierce Pharma

Amgen cuts 500 U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital Fierce Pharma

Third Akorn sterile drug plant hit by FDA as new CEO lays out blueprint for a better future - Fierce Pharma

Third Akorn sterile drug plant hit by FDA as new CEO lays out blueprint for a better future Fierce Pharma

Teva signs deal with Bioeq for ranibizumab biosimilar FYB201 - Generics and Biosimilars Initiative

Teva signs deal with Bioeq for ranibizumab biosimilar FYB201 Generics and Biosimilars Initiative

AbbVie signs another licensing deal for adalimumab biosimilar - Generics and Biosimilars Initiative

AbbVie signs another licensing deal for adalimumab biosimilar Generics and Biosimilars Initiative

Lumos Pharma Closes $38M Acquisition Deal with Double Point Ventures, Offers Premium Plus CVR Rights - Stock Titan

Lumos Pharma Closes $38M Acquisition Deal with Double Point Ventures, Offers Premium Plus CVR Rights Stock Titan

Aridis Pharma Secures $6.5M Asset Deal for AR-501, Advances Phase 3 Investment Plans - Stock Titan

Aridis Pharma Secures $6.5M Asset Deal for AR-501, Advances Phase 3 Investment Plans Stock Titan

Mayne Pharma’s net losses more than double - AFR

Mayne Pharma’s net losses more than double AFR

Sun Pharma Q4 net rises 34% to ₹2,654 crore - The Hindu

Sun Pharma Q4 net rises 34% to ₹2,654 crore The Hindu

Sun Pharma Q3FY25 results: Net profit soars 15%, revenue up 10.5% - Business Standard

Sun Pharma Q3FY25 results: Net profit soars 15%, revenue up 10.5% Business Standard

LEO Pharma commits to net-zero greenhouse gas emissions by 2050 - Via Ritzau

LEO Pharma commits to net-zero greenhouse gas emissions by 2050 Via Ritzau

Torrent Pharma Q1 Result | Net profit rises 20% to ₹548 crore; revenue, margin improves - CNBC TV18

Torrent Pharma Q1 Result | Net profit rises 20% to ₹548 crore; revenue, margin improves CNBC TV18

Anuh Pharma Standalone March 2025 Net Sales at Rs 198.14 crore, up 20.9% Y-o-Y - Moneycontrol

Anuh Pharma Standalone March 2025 Net Sales at Rs 198.14 crore, up 20.9% Y-o-Y Moneycontrol

Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoY - The Economic Times

Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoY The Economic Times

Sun Pharma Q2 net up 5% at Rs 2,375 crore - Zee Business

Sun Pharma Q2 net up 5% at Rs 2,375 crore Zee Business

Sun Pharma Q3 Results: Net profit up 15%; revenue at Rs 13,675 crore - Zee Business

Sun Pharma Q3 Results: Net profit up 15%; revenue at Rs 13,675 crore Zee Business

Top Net-Pharma Hub Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant